XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
3 Months Ended
Apr. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity Under Equity Incentive Plans and Related Information

The following table summarizes the stock option activity under the equity incentive plans and related information:

 

 

 

Shares Subject to Options Outstanding

 

 

Weighted-
Average

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

 

 

 

 

 

 

 

Average Exercise

 

 

Contractual Life

 

 

Aggregate

 

 

 

Shares

 

 

Price

 

 

(Years)

 

 

Intrinsic Value

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

Balance as of January 31, 2023

 

 

2,373,063

 

 

$

17.32

 

 

 

3.81

 

 

$

34,820

 

Options exercised

 

 

(19,440

)

 

 

5.78

 

 

 

 

 

 

 

Options forfeited/cancelled

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of April 30, 2023

 

 

2,353,623

 

 

$

17.41

 

 

 

3.59

 

 

$

21,331

 

Exercisable as of April 30, 2023

 

 

2,353,623

 

 

$

17.41

 

 

 

3.59

 

 

$

21,331

 

Summary of Restricted Stock Unit Activity Under Equity Incentive Plans and Related Information

The following table summarizes the restricted stock unit activity under the equity incentive plans and related information:

 

 

 

Number of

 

 

Weighted-

 

 

 

Restricted

 

 

Average

 

 

 

Stock Units

 

 

Grant Date

 

 

 

Outstanding

 

 

Fair Value

 

Unvested balance - January 31, 2023

 

 

14,665,753

 

 

$

24.89

 

Granted

 

 

7,023,888

 

 

 

26.44

 

Vested

 

 

(2,225,935

)

 

 

23.83

 

Forfeited/cancelled

 

 

(208,799

)

 

 

24.92

 

Unvested balance - April 30, 2023

 

 

19,254,907

 

 

$

25.58

 

Summary of Components of Stock-Based Compensation Expense

The following table summarizes the components of stock-based compensation expense recognized in the condensed consolidated statements of operations (in thousands):

 

 

 

Three Months Ended

 

 

 

April 30,

 

 

 

2023

 

 

2022

 

Cost of revenue

 

$

4,485

 

 

$

4,355

 

Research and development

 

 

17,002

 

 

 

17,726

 

Sales and marketing

 

 

15,318

 

 

 

15,289

 

General and administrative

 

 

10,472

 

 

 

9,740

 

Total stock-based compensation

 

$

47,277

 

 

$

47,110